Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the poss...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anatoly Urisman, Ross J Molinaro, Nicole Fischer, Sarah J Plummer, Graham Casey, Eric A Klein, Krishnamurthy Malathi, Cristina Magi-Galluzzi, Raymond R Tubbs, Don Ganem, Robert H Silverman, Joseph L DeRisi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2006
Materias:
Acceso en línea:https://doaj.org/article/fe3f8c4939fb4609b265344ee8a99a5d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe3f8c4939fb4609b265344ee8a99a5d
record_format dspace
spelling oai:doaj.org-article:fe3f8c4939fb4609b265344ee8a99a5d2021-11-25T05:46:26ZIdentification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.1553-73661553-737410.1371/journal.ppat.0020025https://doaj.org/article/fe3f8c4939fb4609b265344ee8a99a5d2006-03-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.0020025https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the possibility that a viral infection might contribute to prostate cancer in individuals harboring the R462Q variant. A viral detection DNA microarray composed of oligonucleotides corresponding to the most conserved sequences of all known viruses identified the presence of gammaretroviral sequences in cDNA samples from seven of 11 R462Q-homozygous (QQ) cases, and in one of eight heterozygous (RQ) and homozygous wild-type (RR) cases. An expanded survey of 86 tumors by specific RT-PCR detected the virus in eight of 20 QQ cases (40%), compared with only one sample (1.5%) among 66 RQ and RR cases. The full-length viral genome was cloned and sequenced independently from three positive QQ cases. The virus, named XMRV, is closely related to xenotropic murine leukemia viruses (MuLVs), but its sequence is clearly distinct from all known members of this group. Comparison of gag and pol sequences from different tumor isolates suggested infection with the same virus in all cases, yet sequence variation was consistent with the infections being independently acquired. Analysis of prostate tissues from XMRV-positive cases by in situ hybridization and immunohistochemistry showed that XMRV nucleic acid and protein can be detected in about 1% of stromal cells, predominantly fibroblasts and hematopoietic elements in regions adjacent to the carcinoma. These data provide to our knowledge the first demonstration that xenotropic MuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention or clearance of infection in vivo. These findings also raise questions about the possible relationship between exogenous infection and cancer development in genetically susceptible individuals.Anatoly UrismanRoss J MolinaroNicole FischerSarah J PlummerGraham CaseyEric A KleinKrishnamurthy MalathiCristina Magi-GalluzziRaymond R TubbsDon GanemRobert H SilvermanJoseph L DeRisiPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 2, Iss 3, p e25 (2006)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Anatoly Urisman
Ross J Molinaro
Nicole Fischer
Sarah J Plummer
Graham Casey
Eric A Klein
Krishnamurthy Malathi
Cristina Magi-Galluzzi
Raymond R Tubbs
Don Ganem
Robert H Silverman
Joseph L DeRisi
Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
description Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the possibility that a viral infection might contribute to prostate cancer in individuals harboring the R462Q variant. A viral detection DNA microarray composed of oligonucleotides corresponding to the most conserved sequences of all known viruses identified the presence of gammaretroviral sequences in cDNA samples from seven of 11 R462Q-homozygous (QQ) cases, and in one of eight heterozygous (RQ) and homozygous wild-type (RR) cases. An expanded survey of 86 tumors by specific RT-PCR detected the virus in eight of 20 QQ cases (40%), compared with only one sample (1.5%) among 66 RQ and RR cases. The full-length viral genome was cloned and sequenced independently from three positive QQ cases. The virus, named XMRV, is closely related to xenotropic murine leukemia viruses (MuLVs), but its sequence is clearly distinct from all known members of this group. Comparison of gag and pol sequences from different tumor isolates suggested infection with the same virus in all cases, yet sequence variation was consistent with the infections being independently acquired. Analysis of prostate tissues from XMRV-positive cases by in situ hybridization and immunohistochemistry showed that XMRV nucleic acid and protein can be detected in about 1% of stromal cells, predominantly fibroblasts and hematopoietic elements in regions adjacent to the carcinoma. These data provide to our knowledge the first demonstration that xenotropic MuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention or clearance of infection in vivo. These findings also raise questions about the possible relationship between exogenous infection and cancer development in genetically susceptible individuals.
format article
author Anatoly Urisman
Ross J Molinaro
Nicole Fischer
Sarah J Plummer
Graham Casey
Eric A Klein
Krishnamurthy Malathi
Cristina Magi-Galluzzi
Raymond R Tubbs
Don Ganem
Robert H Silverman
Joseph L DeRisi
author_facet Anatoly Urisman
Ross J Molinaro
Nicole Fischer
Sarah J Plummer
Graham Casey
Eric A Klein
Krishnamurthy Malathi
Cristina Magi-Galluzzi
Raymond R Tubbs
Don Ganem
Robert H Silverman
Joseph L DeRisi
author_sort Anatoly Urisman
title Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
title_short Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
title_full Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
title_fullStr Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
title_full_unstemmed Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.
title_sort identification of a novel gammaretrovirus in prostate tumors of patients homozygous for r462q rnasel variant.
publisher Public Library of Science (PLoS)
publishDate 2006
url https://doaj.org/article/fe3f8c4939fb4609b265344ee8a99a5d
work_keys_str_mv AT anatolyurisman identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT rossjmolinaro identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT nicolefischer identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT sarahjplummer identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT grahamcasey identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT ericaklein identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT krishnamurthymalathi identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT cristinamagigalluzzi identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT raymondrtubbs identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT donganem identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT roberthsilverman identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
AT josephlderisi identificationofanovelgammaretrovirusinprostatetumorsofpatientshomozygousforr462qrnaselvariant
_version_ 1718414498010759168